Search - tctmd.com

Displaying 141 - 160 of 1227

Sort: Relevancy | Date

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

Presentation TCT 2024

Creative Uses of AI in Imaging for Structural Heart Disease

Presenter: Partho Sengupta

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Presentation TCT 2024

Detecting Structural Heart Disease from Electrocardiograms Using Deep Learning: The DISCOVERY Study and the Multicenter Development and Validation of the EchoNext Model

Presenter: Timothy Poterucha

October 30, 2024

Presentation TCT 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Alexander Lauten

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Mark Lebehn

October 30, 2024

Presentation TCT 2024

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Case Resolution

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

Case Presentation

Presenter: Nino Mihatov

October 30, 2024

Presentation TCT 2024

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

POINT: TAVR Will Reign Supreme!

Presenter: Vinod Thourani

October 30, 2024

Presentation TCT 2024

COUNTERPOINT: The Surgical Standard Will Predominate!

Presenter: Michael Bowdish

October 30, 2024

Presentation TCT 2024

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

Presenter: Joshua Zuniga

October 30, 2024

Presentation TCT 2024

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

Presenter: Yousif Ahmad

October 30, 2024

Presentation TCT 2024

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

Presenter: Didier Tchetche

October 30, 2024

Presentation TCT 2024

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presenter: Deepak Bhatt

October 29, 2024

Presentation TCT 2024

TCT 1285: Simultaneous Combined Procedure of Edge-to-Edge Transcatheter Mitral Repair (M-TEER) and Heterotopic Transcatheter Tricuspid Valve Replacement for Complex Multivalvular Disease

Presenter: Cristiano Bezerra

October 29, 2024

Presentation TCT 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

My Most Important Lessons Learned from Treating Multivalve Disease

Presenter: NULL

October 29, 2024

Advertisement

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Creative Uses of AI in Imaging for Structural Heart Disease

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Detecting Structural Heart Disease from Electrocardiograms Using Deep Learning: The DISCOVERY Study and the Multicenter Development and Validation of the EchoNext Model

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Case Presentation

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Case Resolution

Case Presentation

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

POINT: TAVR Will Reign Supreme!

COUNTERPOINT: The Surgical Standard Will Predominate!

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

TCT 1285: Simultaneous Combined Procedure of Edge-to-Edge Transcatheter Mitral Repair (M-TEER) and Heterotopic Transcatheter Tricuspid Valve Replacement for Complex Multivalvular Disease

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

My Most Important Lessons Learned from Treating Multivalve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content